Cargando…
An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273850/ https://www.ncbi.nlm.nih.gov/pubmed/32574238 http://dx.doi.org/10.3389/fphar.2020.00856 |
| _version_ | 1783542486272049152 |
|---|---|
| author | Terrazzano, Giuseppe Rubino, Valentina Palatucci, Anna Teresa Giovazzino, Angela Carriero, Flavia Ruggiero, Giuseppina |
| author_facet | Terrazzano, Giuseppe Rubino, Valentina Palatucci, Anna Teresa Giovazzino, Angela Carriero, Flavia Ruggiero, Giuseppina |
| author_sort | Terrazzano, Giuseppe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7273850 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72738502020-06-15 An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Terrazzano, Giuseppe Rubino, Valentina Palatucci, Anna Teresa Giovazzino, Angela Carriero, Flavia Ruggiero, Giuseppina Front Pharmacol Pharmacology Frontiers Media S.A. 2020-05-29 /pmc/articles/PMC7273850/ /pubmed/32574238 http://dx.doi.org/10.3389/fphar.2020.00856 Text en Copyright © 2020 Terrazzano, Rubino, Palatucci, Giovazzino, Carriero and Ruggiero http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Terrazzano, Giuseppe Rubino, Valentina Palatucci, Anna Teresa Giovazzino, Angela Carriero, Flavia Ruggiero, Giuseppina An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
| title | An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
| title_full | An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
| title_fullStr | An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
| title_full_unstemmed | An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
| title_short | An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? |
| title_sort | open question: is it rational to inhibit the mtor-dependent pathway as covid-19 therapy? |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273850/ https://www.ncbi.nlm.nih.gov/pubmed/32574238 http://dx.doi.org/10.3389/fphar.2020.00856 |
| work_keys_str_mv | AT terrazzanogiuseppe anopenquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT rubinovalentina anopenquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT palatucciannateresa anopenquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT giovazzinoangela anopenquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT carrieroflavia anopenquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT ruggierogiuseppina anopenquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT terrazzanogiuseppe openquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT rubinovalentina openquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT palatucciannateresa openquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT giovazzinoangela openquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT carrieroflavia openquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy AT ruggierogiuseppina openquestionisitrationaltoinhibitthemtordependentpathwayascovid19therapy |